نتائج البحث 1381-1390 من 21002 لعملية البحث عن WHO
... who have risk factors for atrial fibrillation and ischemic stroke. Breast Cancer: Can We Predict Pathological Complete Response following Neoadjuvant ...
The purpose of this study is to assess the side effects and best dose of a genetically engineered measles virus for treating patients who have a cancerous ...
Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...
The purpose of this study is to compare change in SNOT-22 score in patients who received medication therapy such as oral antibiotics, topical antibiotics ...
... who have stage IV metastatic melanoma. Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma or CCUS. Rochester ...
... who have normal risk factors in order to improve the ability to diagnose and treat these cancers. We will use information in the medical record in this ...
... who are candidates for active surveillance and are undergoing voluntary radical prostatectomy (RP) [Cohort A] or routine prostate biopsy [Cohort B]. This ...
يمكنك العثور على عبوات مسحوق أملاح تعويض السوائل عن طريق الفم، التي تحمل علامة منظمة الصحة العالمية (World Health Organization (WHO)-ORS)، في المتاجر والصيدليات ...
Subjects who received at least one GM T cell infusion, will be asked to roll-over to this LTFU protocol upon either premature discontinuation from, or ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.